Interaction of the novel GH secretagogue hexarelin with GHRH in regulating the secretion of GH by cultured human pituitary somatotrophinomas in vitro

Liu Qin , Lei Ting , Liu Kui , Lin Wen , Eric F. Adams

Current Medical Science ›› 2000, Vol. 20 ›› Issue (2) : 109 -111.

PDF
Current Medical Science ›› 2000, Vol. 20 ›› Issue (2) :109 -111. DOI: 10.1007/BF02887044
Article

Interaction of the novel GH secretagogue hexarelin with GHRH in regulating the secretion of GH by cultured human pituitary somatotrophinomas in vitro

Author information +
History +
PDF

Abstract

The effects of the novel GH-releasing hexapeptide, Hexarelin, on the secretion of GH in cultured human pituitary somatotrophinomas was further investigated. Hexarelin (20 nmol / L) strongly stimulated GH secretion, which could be reduced by phloretin, but not by RP-cAMPS, an inhibitor of protein kinase A(PKA). (Ac-Tyrl,D-Arg2)-GRF(l-29)-NH2 failed to block the effects of Hexarelin but completely abolished the stimulation of GH secretion exerted by GHRH. When added alone to somatotrophinoma cell cultures, Hexarelin had no effect on cAMP levels, but it potentiated the stimulatory effects of GHRH. These results demonstrated that Hexarelin could directly stimulate GH secretion by human pituitary somatotrophs PKC-dependently, which might be contributed to the activation of the PI transduction system. In addition, Hexarelin could interact with GHRH on the adenylyl cyclase system.

Keywords

Hexarelin / somatotrophinomas / cAMP / growth hormone / pituitary

Cite this article

Download citation ▾
Liu Qin, Lei Ting, Liu Kui, Lin Wen, Eric F. Adams. Interaction of the novel GH secretagogue hexarelin with GHRH in regulating the secretion of GH by cultured human pituitary somatotrophinomas in vitro. Current Medical Science, 2000, 20(2): 109-111 DOI:10.1007/BF02887044

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

LiuQ, LeiT, LiuK, et al.. Effects of the novel GH secretagogue, Hexarelin on GH secretion and PI hydrolysis by human pituitary somatotrophinomas in cell culture. J Tongji Med Univ, 1999, 19: 277-277

[2]

BowersC Y.. Editorial: On a peptidomimetic growth hormone-releasing peptide. J Clin Endocrinol Metab, 1994, 79: 940-940

[3]

DeghenghiR, CananziM M, TorselloA, et al.. GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats. Life Sci, 1994, 54: 1321-1321

[4]

WuD, ChenC, KatohK, et al.. The effect of GH-releasing peptide-2 (GHRP-2 or KP 102) on GH secretion from primary cultured ovine pituitary cells can be abolished by a specific GH-releasing factor (GRF) receptor antagonist. J Endocrinol, 1994, 140: R9-R9

[5]

LeiT, BuchfelderM, FahlbuschR.. Growth hormone releasing peptide (GHRP-6) stimulates phosphatidylinositol (PI) turnover in human pituitary somatotrophinoma cells. J Mol Endocrinol, 1995, 14: 135-135

[6]

LiuQ, LeiT, AdamsE F, et al.. Relationship between GHRP-6 and TPA in the regulation of GH secretion by human pituitary somatotrophinomas. J Tongji Med Univ, 1997, 17: 52-52

[7]

HouslayM D.. “Crosstalk”: a pivotal role for protein kinase C in modulating relationships between signal transduction pathways. Eur J Biochem, 1991, 195: 9-9

[8]

KawabeJ, IwamiG, EbinaT, et al.. Differential activation of adenylyl cyclase by protein kinase C isoenzymes. J Biol Chem, 1994, 269: 16554-16554

AI Summary AI Mindmap
PDF

134

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/